| Product Code: ETC7356189 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Pharmacogenetic Testing Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Greece Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Greece Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Greece Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine in Greece |
4.2.3 Government initiatives promoting the adoption of precision medicine |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing in Greece |
4.3.2 Lack of standardized guidelines for pharmacogenetic testing implementation |
4.3.3 High initial costs associated with setting up pharmacogenetic testing facilities |
5 Greece Pharmacogenetic Testing Market Trends |
6 Greece Pharmacogenetic Testing Market, By Types |
6.1 Greece Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Greece Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Greece Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Greece Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Greece Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Greece Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Greece Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Greece Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Greece Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Greece Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Greece Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Greece Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Greece Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Greece Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Greece Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Greece Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Greece Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Greece Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Greece Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Greece Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Greece Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Greece Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Greece Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Greece Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Greece Pharmacogenetic Testing Market Export to Major Countries |
7.2 Greece Pharmacogenetic Testing Market Imports from Major Countries |
8 Greece Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in pharmacogenetic testing |
8.2 Adoption rate of pharmacogenetic testing by healthcare facilities |
8.3 Number of government-funded programs supporting pharmacogenetic testing |
8.4 Patient satisfaction levels with pharmacogenetic testing services |
8.5 Rate of integration of pharmacogenetic testing into clinical practice |
9 Greece Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Greece Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Greece Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Greece Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Greece Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Greece Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here